COLUMBIA, Md., Dec. 10, 2020 /PRNewswire/ — The Basis Combating Blindness, the world’s main group dedicated to discovering remedies and cures for blinding retinal illnesses, has introduced the appointment of Peter Ginsberg as government vp, company growth, chief enterprise officer. Mr. Ginsberg will oversee the event of economic plans and processes whereas offering management on enterprise transactions, strategic planning, and new actions geared toward creating novel income streams throughout the Foundation Fighting Blindness and RD Fund. He’ll report back to the Basis’s chief government officer, Ben Yerxa, PhD.
“I’ve identified Peter for a few years and am privileged to deliver his intensive enterprise growth and finance experience to this new function,” commented Ben Yerxa. “Not solely has he led record-setting transactions with massive and small biopharmaceutical firms, he has labored extensively inside ophthalmology, impressed by his long-time mentor who has retinitis pigmentosa.”
“Becoming a member of the Basis is a superb honor, and I stay up for constructing on our present packages and creating new avenues to speed up achievement of our mission,” added Peter Ginsberg.
Most just lately, Mr. Ginsberg served as vp of enterprise growth at Savara Prescribed drugs (SVRA), an orphan lung illness firm. Beforehand, he headed enterprise growth for BioDelivery Sciences (BDSI), United Therapeutics (UTHR), and SurModics (SRDX). Ginsberg additionally served as VP of enterprise & expertise growth for the North Carolina Biotechnology Middle, the place his group financed and suggested rising life science firms. He additional spent 15 years within the healthcare funding trade, throughout which period he was named a Wall Avenue Journal All-Star as Piper Jaffray’s lead biotechnology analyst.
Ginsberg serves as a board member for First Flight Enterprise Middle and is a Chartered Monetary Analyst and member of the CFA Institute. He earned an A.B. in Economics from Princeton College and an M.B.A. from the Tuck Faculty of Enterprise at Dartmouth Faculty.
Concerning the Basis Combating Blindness
Established in 1971, the Basis Combating Blindness is the world’s main non-public funding supply for retinal degenerative illness analysis. The Basis has raised greater than $800 million towards its mission of accelerating analysis for stopping, treating, and curing blindness attributable to the whole spectrum of retinal degenerative illnesses together with: retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and Stargardt illness. Go to FightingBlindness.org for extra info.
Vice President, Advertising & Communications
SOURCE Basis Combating Blindness